Effects of resuscitation with human albumin 5%, hydroxyethyl starch 130/0.4 6%, or crystalloid on kidney damage in an ovine model of septic shock

Br J Anaesth. 2018 Sep;121(3):581-587. doi: 10.1016/j.bja.2018.04.041. Epub 2018 Jun 1.

Abstract

Background: Colloid solutions have been associated with kidney dysfunction in septic animals and humans. The present study investigated the influence of resuscitation with human albumin (HA) 5%, hydroxyethyl starch (HES) 130/0.4 6%, and balanced crystalloids on ultrastructural kidney damage, kidney function, and survival in a model of ovine septic shock.

Methods: After induction of peritoneal septic shock, animals were randomised to one of the following groups: (1) HA 5%, (2) HES 130/0.4 6%, (3) balanced crystalloid, and (4) control (each n=10). Causal therapy included re-laparotomy, peritoneal lavage, and antimicrobial therapy. Sequential kidney biopsies were obtained for the assessment of the electron microscopic tubular injury (EMTI) score.

Results: Serum creatinine and urea were highest in the control group, and there were no differences between the intervention groups. Cumulative diuresis was significantly higher in the HA group [1.0 ml kg-1 h-1 (0.6; 1.2)] compared with control [0.7 ml kg-1 h-1 (0.6; 0.9), P<0.05]. Creatinine clearance was highest in the HA and crystalloid groups. Ultrastructural kidney damage was highest in the control group [EMTI score 7.8 (6.7; 9.0)] without differences between intervention groups. Survival was 100% in the colloid groups vs 90% (crystalloid) and 60% (control, all P<0.05).

Conclusion: In an ovine model of septic shock, kidney function and cumulative diuresis were preserved in the 5% albumin and crystalloid resuscitation groups, whereas HES 130/0.4 6% resulted in diminished creatinine clearance. Differences in kidney function between resuscitation fluids could not be explained by differences in ultrastructural kidney damage.

Clinical trial registration: 84-02.04.2011.A300.

Keywords: HES 130–0.4; acute kidney injury; fluid therapy; septic shock; serum albumin.

Publication types

  • Comparative Study

MeSH terms

  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / physiopathology
  • Animals
  • Creatinine / blood
  • Crystalloid Solutions / therapeutic use
  • Crystalloid Solutions / toxicity*
  • Disease Models, Animal
  • Drug Administration Schedule
  • Female
  • Fluid Therapy / adverse effects
  • Fluid Therapy / methods
  • Hemodynamics / physiology
  • Hydroxyethyl Starch Derivatives / therapeutic use
  • Hydroxyethyl Starch Derivatives / toxicity*
  • Norepinephrine / administration & dosage
  • Oxygen Consumption / physiology
  • Random Allocation
  • Serum Albumin, Human / therapeutic use
  • Serum Albumin, Human / toxicity*
  • Sheep, Domestic
  • Shock, Septic / physiopathology
  • Shock, Septic / therapy*
  • Vasoconstrictor Agents / administration & dosage

Substances

  • Crystalloid Solutions
  • Hydroxyethyl Starch Derivatives
  • Vasoconstrictor Agents
  • Creatinine
  • Norepinephrine
  • Serum Albumin, Human